WHRY Funds Studies on Stroke, Endometrial Cancer, and Addiction to Opioids
Women’s Health Research at Yale today announced funding for three studies investigating sex differences in stroke, endometrial cancer, and alternate pain relief for women recovering from past opioid use who are giving birth via cesarean section.
High exposure to harmful chemical impacts thyroid hormones in pregnant mothers
Studies conducted by Assistant Professor, Zeyan Liew, at the Yale School of Public Health, focus on a group of harmful chemicals known as PFAS (per- and polyfluoroalkyl substances) that can affect hormones during pregnancy crucial to fetal development. Efforts are underway by Yale professors, Dr. Krystal Pollitt and Dr. John Fortner, to investigate the chemical structures and ban the use of PFAS as well as determine routes for removing or destroying the substances from the environment.Source: Yale Daily News
Study: Accuracy of Five Self‐Report Screening Instruments for Substance Use in Pregnancy
Nearly one-fourth of pregnant women report having used alcohol, tobacco, or other substances in the past month, yet current screening questionnaires used by physicians may not accurately identify many of them. Kimberly A. Yonkers, MD, Professor of Psychiatry, of Epidemiology (Chronic Diseases) and of Obstetrics, Gynecology, and Reproductive Services at Yale School of Medicine, was the senior researcher among investigators across three universities who compared results of five commonly used questionnaires against laboratory testing.
Better Science, Better Lives: Women's Health Research at Yale is Working for You
Across the country, it’s becoming clearer every day: We must study the health of women. We must study the influence of sex-and-gender differences on health. And it’s time for all aspects of medical research and practice to embrace this change.
HEALTH NOTES: Aggressive Uterine Cancer Rates Are Rising in the U.S., Especially for Minority Women
Women in the United States have experienced a steep rise in rates of aggressive uterine cancer since 2000, an upward trend that has been particularly steep for minority women, according to a new study.
Iwasaki Is Honored by the International Cytokine & Interferon Society
Akiko Iwasaki, PhD, Waldemar Von Zedtwitz Profesor of Immunobiology and Molecular, Cellular, and Developmental Biology; and professor of dermatology, is a 2019 recipient of the Seymour & Vivian Milstein Award for Excellence in Interferon and Cytokine Research, given by the International Cytokine & Interferon Society (ICIS).
Don't Jump for Joy over New FDA-approved Postpartum Depression Medicine Yet
Kimberly Yonkers, MD, Professor of Psychiatry, of Epidemiology (Chronic Diseases) and of Obstetrics, Gynecology, and Reproductive Sciences cautions new mothers who may consider taking the new FDA-approved medication for postpartum depression in an opinion piece published in USA Today.Source: USA Today
Improving the Health of Pregnant Women
More than six million women are pregnant in the United States in any given year, and more than 90 percent of these women will take at least one medication. But clinical studies of medications, diseases, and conditions often exclude pregnant and lactating women, leaving women and their caregivers guessing about how pregnancy and childbirth affect the efficacy and safety of particular treatments.
Preventing Viral Infections During Pregnancy
Dr. Michelle Silasi, Assistant Professor of Obstetrics, Gynecology, and Reproductive Sciences, will test the effectiveness of a new technique to screen for viral exposure during pregnancy that can identify women at risk for serious complications and allow for interventions to improve pregnancy outcomes.
Raising the Volume: Yale student-run biomedical journal focuses on sex and gender
One of the primary missions of Women’s Health Research at Yale is training the next generation of scientists to study the influence of sex and gender. And perhaps there is no one better to voice that necessity than a member of that generation.
Hope for women with recurring pregnancy losses
For some, every pregnancy ends in a loss within six weeks. “These particular patients always have losses and they are not infertile. They get pregnant easily but they always have these losses,” says Dr. Harvey Kliman, director of the Reproductive and Placental Research Unit in the Department of Obstetrics, Gynecology and Reproductive Sciences at Yale School of Medicine.Source: WTNH
Progesterone may be key to preventing recurrent miscarriage
For women who suffer multiple pregnancy losses in the first four to six weeks of gestation, the hormone progesterone could offer hope for a successful birth, according to a new study by Yale School of Medicine researchers and their colleagues at University of Illinois at Chicago.